×
ADVERTISEMENT

NOVEMBER 21, 2023

Environmental Monitoring for Sterile Hazardous Drug Compounding


Originally published by our sister publication Pharmacy Practice News

Fred Massoomi, PharmD, RPh, BCSCP, FASHP
Senior Consultant
Visante
St. Paul, Minn.
James Jorgenson, RPh, MS, FASHP
CEO
Visante
St. Paul, Minn.

Compounding safe sterile preparations requires harmonization of people, processes and engineering controls. With hazardous drugs, the additional element of healthcare provider safety must be included. Often when environmental monitoring is discussed in the context of hazardous drugs, the lens